Industry NewsDrug Discovery & Development European Commission approves Roche’s Gazyva/Gazyvaro for adults with active lupus nephritis
Industry NewsEuropean Commission approves Roche’s Gazyva/Gazyvaro for adults with active lupus nephritis
